Form D · Other
Advanced Bio Development, Inc.
Englewood Cliffs, NJ · CIK 0001696505
Offering snapshot reported May 27, 2021 · SEC filing
- Reported sold
- $14.1M Offering amount: $16M
- Investors reported
- 23 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 1, 2020 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$12,000,000 → $14,065,879
- Reported investors12 → 23
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 27, 2021 | Amendment | $14,065,879 | $2,065,879vs Sep 9, 2020 | 23 | SEC filing |
| Sep 9, 2020 | Initial | $12,000,000 | No comparison | 12 | SEC filing |
| Dec 26, 2019 | Initial | $1,000,000 | No comparison | 1 | SEC filing |
| Dec 6, 2019 | Initial | $750,000 | No comparison | 2 | SEC filing |
| Jul 9, 2018 | Initial | $8,075,849 | No comparison | 1 | SEC filing |
| Feb 6, 2017 | Initial | $4,274,315 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Debt, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-375082
The Company has increased the offering size to $16,000,000 of new investment. We are amending this amount to include all securities sold since September 1, 2020.
Source: Form D, filed May 27, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| M. Todd Bartee | Director |
| Christopher Casgar | Director |
| Scott Dahnke | Director |
| Michael Farello | Director |
| Ralph Ferrante | Director |
| Mark French | Director, Executive |
| Scott Greene | Executive |
| Sandra Karpman | Executive |
| Kawhi Leonard | Director |
| Jonathan London | Executive |
| Michael Miller | Executive |
| Joseph Poli | Executive |
| Dennis Robertson | Director |
| Michael Tannenbaum | Director |
Issuer details
Industry: Other (See others in industry)
Address:
270 Sylvan Avenue Suite 2230
Englewood Cliffs, NJ, 07632
Englewood Cliffs, NJ, 07632